Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation - PubMed (original) (raw)
. 1996 May 1;15(9):2174-83.
Affiliations
- PMID: 8641283
- PMCID: PMC450141
Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
G Bunone et al. EMBO J. 1996.
Abstract
The estrogen receptor (ER) can be activated as a transcription factor either by binding of cognate estrogenic ligand or, indirectly, by a variety of other extracellular signals. As a first step towards elucidating the mechanism of 'steroid-independent activation' of the ER by the epidermal growth factor (EGF), we have mapped the ER target domain and determined the signaling pathway. We show that the N-terminal transcriptional activation function AF-1, but not the C-terminal AF-2, is necessary for the EGF response. Both the EGF-induced hyperphosphorylation and the transcriptional activation of the unliganded ER depend on a phosphorylatable serine residue at position 118. However, its phosphorylation is not sufficient and, hence, there must be other target domains or proteins which fulfill an additional requirement for EGF signaling through the ER. Using dominant-negative Ras and MAP kinase kinase (MAPK kinase) and constitutively active MAPK kinase mutants, we show that EGF activates the ER by signaling through the MAPK pathway suggesting that MAPK directly phosphorylates the critical serine 118. Our results also imply that the steroid-independent activation of a variety of ER mutants, which arise during the malignant progression of breast tumors, may contribute to tamoxifen resistance.
Similar articles
- Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway.
Feng W, Webb P, Nguyen P, Liu X, Li J, Karin M, Kushner PJ. Feng W, et al. Mol Endocrinol. 2001 Jan;15(1):32-45. doi: 10.1210/mend.15.1.0590. Mol Endocrinol. 2001. PMID: 11145737 - Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.
Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P. Kato S, et al. Science. 1995 Dec 1;270(5241):1491-4. doi: 10.1126/science.270.5241.1491. Science. 1995. PMID: 7491495 - pp90rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167.
Joel PB, Smith J, Sturgill TW, Fisher TL, Blenis J, Lannigan DA. Joel PB, et al. Mol Cell Biol. 1998 Apr;18(4):1978-84. doi: 10.1128/MCB.18.4.1978. Mol Cell Biol. 1998. PMID: 9528769 Free PMC article. - Cross-talk between peptide growth factor and estrogen receptor signaling pathways.
Smith CL. Smith CL. Biol Reprod. 1998 Mar;58(3):627-32. doi: 10.1095/biolreprod58.3.627. Biol Reprod. 1998. PMID: 9510949 Review. - Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.
Kurokawa H, Arteaga CL. Kurokawa H, et al. Clin Cancer Res. 2001 Dec;7(12 Suppl):4436s-4442s; discussion 4411s-4412s. Clin Cancer Res. 2001. PMID: 11916237 Review.
Cited by
- Phosphorylation: a fundamental regulator of steroid receptor action.
Treviño LS, Weigel NL. Treviño LS, et al. Trends Endocrinol Metab. 2013 Oct;24(10):515-24. doi: 10.1016/j.tem.2013.05.008. Epub 2013 Jul 6. Trends Endocrinol Metab. 2013. PMID: 23838532 Free PMC article. Review. - Prosaposin, a regulator of estrogen receptor alpha, promotes breast cancer growth.
Wu Y, Sun L, Zou W, Xu J, Liu H, Wang W, Yun X, Gu J. Wu Y, et al. Cancer Sci. 2012 Oct;103(10):1820-5. doi: 10.1111/j.1349-7006.2012.02374.x. Epub 2012 Aug 10. Cancer Sci. 2012. PMID: 22738294 Free PMC article. - Ubiquitylation of nuclear receptors: new linkages and therapeutic implications.
Helzer KT, Hooper C, Miyamoto S, Alarid ET. Helzer KT, et al. J Mol Endocrinol. 2015 Jun;54(3):R151-67. doi: 10.1530/JME-14-0308. Epub 2015 May 5. J Mol Endocrinol. 2015. PMID: 25943391 Free PMC article. Review. - LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMP.
Bennesch MA, Segala G, Wider D, Picard D. Bennesch MA, et al. Nucleic Acids Res. 2016 Oct 14;44(18):8655-8670. doi: 10.1093/nar/gkw522. Epub 2016 Jun 20. Nucleic Acids Res. 2016. PMID: 27325688 Free PMC article. - Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
Yamashita H, Nishio M, Kobayashi S, Ando Y, Sugiura H, Zhang Z, Hamaguchi M, Mita K, Fujii Y, Iwase H. Yamashita H, et al. Breast Cancer Res. 2005;7(5):R753-64. doi: 10.1186/bcr1285. Epub 2005 Jul 27. Breast Cancer Res. 2005. PMID: 16168121 Free PMC article.
References
- J Steroid Biochem Mol Biol. 1994 Apr;48(5-6):481-6 - PubMed
- EMBO J. 1987 May;6(5):1309-15 - PubMed
- J Biol Chem. 1995 Mar 10;270(10):5594-9 - PubMed
- Breast Cancer Res Treat. 1994;32(1):49-55 - PubMed
- Science. 1993 Nov 12;262(5136):1069-72 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials